Polyacrylamide mammary syndrome — specificity of the histological pattern of the focus before and after air-plasma treatment
- 作者: Osmanov E.1, Shulutko A.1, Krylov A.1, Gandybina E.1, Malyugina A.1
-
隶属关系:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- 期: 卷 27, 编号 3 (2021)
- 页面: 247-255
- 栏目: Clinical medicine
- URL: https://journals.rcsi.science/0869-2106/article/view/101089
- DOI: https://doi.org/10.17816/0869-2106-2021-27-3-247-255
- ID: 101089
如何引用文章
详细
BACKGROUND: At the end of the twentieth century, mammary gland contour correction using polyacrylamide gel (PAAG) became widely popular. The surgical approach must be improved because of the negative consequences associated with this technique.
AIM: This study aimed to evaluate the possibilities of air-plasma technology in the treatment of long-term septic manifestations of polyacrylamide mammary syndrome as well as the prevention of its recurrence based on the analysis of histological examination findings.
MATERIALS AND METHODS: Biopsy samples of eight women aged 38 to 59 years, who had undergone gel augmentation of the mammary glands six to 20 years ago, were studied. The complex treatment included air-plasma flow in cutting coagulation modes and nitric oxide therapy. A morphological study of the focus was performed before and after exposure to the plasma flow.
RESULTS: Before treatment, chronic granulomatous inflammation and helioma were revealed in six cases; and acute phlegmonous-necrotic soft tissue inflammation in two cases. On the fifth day after combined necrectomy, single loci of the gel were visualized, the majority of which was vaporized. Chronic inflammation was less pronounced than the original histograms. During the sanitation with nitric oxide, the early appearance of foci of fibroblastic proliferation and marginal epithelialization was registered.
CONCLUSIONS: Exposure to the air-plasma flow contributes to effective sanitation of purulent focus and gel total elimination Nitric oxide therapy (NO-therapy) accelerates the development of granulation tissue.
作者简介
Elkhan Osmanov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
编辑信件的主要联系方式.
Email: mma-os@yandex.ru
ORCID iD: 0000-0003-1451-1015
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowAleksandr Shulutko
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: shulutko@mail.ru
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowAleksey Krylov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: doctorwing@mail.ru
ORCID iD: 0000-0003-0328-0223
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowElena Gandybina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: alzas2007@rambler.ru
ORCID iD: 0000-0002-6765-5154
MD, Cand. Sci. (Med.)
俄罗斯联邦, MoscowAnastasiya Malyugina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: nastyona.maliugina@yandex.ru
ORCID iD: 0000-0002-8204-2276
俄罗斯联邦, Moscow
参考
- Xie PB, Shi AP. Application of polyacrylamide hydrogel in augmentation mammoplasty. Di Yi Jun Yi Da Xue Xue Bao. 2002;22(7):648–649.
- Adamjan AA, Svetuhin AM, Skuba ND. Polyacrylamide mammary syndrome: clinical picture, diagnosis, treatment. Annaly plasticheskoj, rekonstruktivnoj i jesteticheskoj hirurgii. 2001;4:20–32. (In Russ).
- Ono S, Ogawa R, Hyakusoku H. Complications after polyacrylamide hydrogel injection for soft-tissue augmentation. Plast Reconstr Surg. 2010;126(4):1349–1357. doi: 10.1097/PRS.0b013e3181ead122
- Milanov NO, Starceva OI, Kelehsaeva MV. Treatment of the negative consequences of augmentation of the mammary glands with polyacrylamide gel. Annaly hirurgii. 2008;4:25–30. (In Russ).
- Lipatov KV, Komarova EA, Nasibov BS, Borodin AV. Diagnosis and treatment of late purulent complications after augmentation mammoplasty. Annaly plasticheskoj, rekonstruktivnoj i jesteticheskoj hirurgii. 2016;2:62–69. (In Russ). doi: 10.18484/2305-0047.2016.4.401
- Cvetkov VO, Kulikova NV, Molchanova VV, Zhdanova AB. Widespread necrotizing cellulitis as a complication of polyacrylamide gel mammoplasty. Hirurgija. Zhurnal im. N.I. Pirogova. 2007;10:37–43. (In Russ).
- Unukovych D, Khrapach V, Wickman M, et al. Polyacrylamide gel injections for breast augmentation: management of complications in 106 patients, a multicenter study. World J Surg. 2012;36(4):695–701. doi: 10.1007/s00268-011-1273-6
- Starceva OI. Reoperations in plastic aesthetic surgery [dissertation]. Moscow; 2007. (In Russ).
- Patlazhan G, Unukovych D, Pshenisnov K. Breast reconstruction and treatment algorithm for patients with complications after polyacrylamide gel injections: a 10-year experience. Aesthetic Plast Surg. 2013;37(2):312–320. doi: 10.1007/s00266-012-0045-5
- Jin R, Luo X, Wang X, et al. Complications and Treatment Strategy After Breast Augmentation by Polyacrylamide Hydrogel Injection: Summary of 10-Year Clinical Experience. Aesthetic Plast Surg. 2018;42(2):402–409. doi: 10.1007/s00266-017-1006-9
- Qian B, Xiong L, Guo K, et al. Comprehensive management of breast augmentation with polyacrylamide hydrogel injection based on 15 years of experience: a report on 325 cases. Ann Transl Med. 2020;8(7):475. doi: 10.21037/atm.2020.03.68
- Peters W., Fornasier V. Complications from injectable materials used for breast augmentation. Can. J. Plast. Surg. 2009;17(3):89–96. doi: 10.1177/229255030901700305
- Margolis NE, Bassiri-Tehrani B, Chhor C, et al. Polyacrylamide gel breast augmentation: report of two cases and review of the literature. Clin Imaging. 2015;39(3):339–343. doi: 10.1016/j.clinimag.2014.12.008
- Dusunceli Atman E, Kul M, Arslan MF, et al. Polyacrylamide gel augmentation mammoplasty: Breast Images. Breast J. 2018;24(3):420–421. doi: 10.1111/tbj.12918
- Xu C, Cao M, Bao B, et al. Tissue degeneration 7 years after breast augmentation with injected polyacrylamide hydrogel (PAAG). Aesthetic Plast. Surg. 2012;36(1):160–162. doi: 10.1007/s00266-011-9779-8
- Wozniak-Roszkowska E, Maslinska M, Gierej P, Noszczyk B. Autoimmune syndrome induced by adjuvants after breast enhancement with polyacrylamide hydrogel: a study in Poland. Rheumatol Int. 2020;40(11):1851–1856. doi: 10.1007/s00296-020-04605-5
- Chen G, Wang Y, Huang JL. Breast cancer following polyacrylamide hydrogel injection for breast augmentation: A case report. Mol Clin Oncol. 2016;4(3):433–435. doi: 10.3892/mco.2016.731
- Luo S, Chen G, Sun Z, Cheng N. Our strategy in complication management of augmentation mammaplasty with polyacrylamide hydrogel injection in 235 patients. J. Plast. Reconstr. Aesthet. Surg. 2011;64(6):731–737. doi: 10.1016/j.bjps.2010.10.004
- Efimenko NA, Hrupkin VI, Marahonich LA. Air plasma flows and NO-therapy are a new technology in the clinical practice of military medical institutions. Voenno-medicinskij zhurnal. 2005;5:51–54. (In Russ).
- Shulutko AM, Osmanov EG, Gogohija TR, Lazhenicyn AI. The strategy of using plasma-arc equipment in purulent surgery. Moskovskij hirurgicheskij zhurnal. 2011;5(21):34–38. (In Russ).
- Shulutko AM, Osmanov EG, Seredin VP, Macharadze AD. Ways of correcting long-term inflammatory-purulent complications of contour mammoplasty with polyacrylamide gel. Annaly plasticheskoj, rekonstruktivnoj i jesteticheskoj hirurgii. 2017;3:33–39. (In Russ).
- Milanov NO, Sidorenkov DA, Chausheva SI. Peculiarities of surgical tactics for the treatment of complications after contour plasty of the lower extremities with polyacrylamide gel. Annaly plasticheskoj, rekonstruktivnoj i jesteticheskoj hirurgii. 2008;4:52–60. (in Russ)
- Danenkov AS, Nikolaev EV, Bojarincev NI. Late complications after augmentation plastic surgery of the mammary glands with polyacrylamide gel. Dal'nevostochnyj medicinskij zhurnal. 2011;1:24–26. (In Russ).
- Shen H, Lv Y, Xu JH, et al. Complications after polyacrylamide hydrogel injection for facial soft-tissue augmentation in China: twenty-four cases and their surgical management. Plast Reconstr Surg. 2012;130(2):340e–348e. doi: 10.1097/PRS.0b013e3182589b7d
- Yu L, Wang J, Zhang B, et al. Treatment of breast injection with polyacrylamide hydrogel with infiltrated fascia capsule removal: report on 104 cases. Aesthetic. Plast. Surg. 2012; 36 (5): 1120–1127. doi: 10.1007/s00266-012-9928-8
- Zarini E, Supino R, Pratesi G, et al. Biocompatibility and tissue interactions of a new filler material for medical use. Plast. Reconstr. Surg. 2004;114:934–942. doi: 10.1097/01.prs.0000133425.22598.d0
- El-Shafey el SI. Complications from repeated injection or puncture of old polyacrylamide gel implant sites: case reports. Aesthetic Plast Surg. 2008;32(1):162–165. doi: 10.1007/s00266-007-9024-7
- Shulutko AM, Osmanov EG, Novikova IV, et al. Plasma treatment in the treatment of late inflammatory-purulent complications of injection contour plastics with polyacrylamide gel. Zhurnal im. N.I. Pirogova. 2017;9:59–63. (In Russ). doi: 10.17116/hirurgia2017959-6
- Manafi A, Emami AH, Pooli AH, et al. Unacceptable results with an accepted soft tissue filler: polyacrylamide hydrogel. Aesthetic Plast Surg. 2010;34(4):413–422. doi: 10.1007/s00266-009-9359-3
- Brjusov PG, Kudrjavcev BP. Plazmennaja hirurgija. [dissertation]. Moscow: Meditsina; 1995. (In Russ).